Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder

[1]  G. Turecki,et al.  Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides , 2016, Molecular Psychiatry.

[2]  T. Schneider-Axmann,et al.  Stereological investigation of the posterior hippocampus in affective disorders , 2015, Journal of Neural Transmission.

[3]  Lachlan T. Strike,et al.  Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group , 2015, Molecular Psychiatry.

[4]  B. Khakh,et al.  Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.

[5]  Kou Takahashi,et al.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease , 2015, Cellular and Molecular Life Sciences.

[6]  Yunan Zhao,et al.  Chronic corticosterone exposure reduces hippocampal astrocyte structural plasticity and induces hippocampal atrophy in mice , 2015, Neuroscience Letters.

[7]  Michael B. First,et al.  Structured Clinical Interview for the DSM (SCID) , 2015 .

[8]  D. Klein,et al.  A review of selected candidate endophenotypes for depression. , 2014, Clinical psychology review.

[9]  M. Szyf,et al.  Astrocytic abnormalities and global DNA methylation patterns in depression and suicide , 2014, Molecular Psychiatry.

[10]  R. Mccoll,et al.  Association of Depressive Symptoms with Hippocampal Volume in 1936 Adults , 2014, Neuropsychopharmacology.

[11]  Carol A. Shively,et al.  Cell Number and Neuropil Alterations in Subregions of the Anterior Hippocampus in a Female Monkey Model of Depression , 2013, Biological Psychiatry.

[12]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[13]  G. Freedman,et al.  Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 , 2013, PLoS medicine.

[14]  B. Bogerts,et al.  S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. , 2013, Journal of psychiatric research.

[15]  G. Rajkowska,et al.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. , 2013, Current drug targets.

[16]  Robert C. Thompson,et al.  Acute and chronic glucocorticoid treatments regulate astrocyte-enriched mRNAs in multiple brain regions in vivo , 2013, Front. Neurosci..

[17]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[18]  E. Aronica,et al.  Glucocorticoid receptor protein expression in human hippocampus; stability with age , 2013, Neurobiology of Aging.

[19]  Gustavo Turecki,et al.  Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. , 2013, Journal of psychiatry & neuroscience : JPN.

[20]  L. Pinto,et al.  Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression , 2013, Molecular Psychiatry.

[21]  M. Walter,et al.  Functional mapping of thalamic nuclei and their integration into cortico-striatal-thalamo-cortical loops via ultra-high resolution imaging—from animal anatomy to in vivo imaging in humans , 2013, Front. Neurosci..

[22]  E. Obuchowicz,et al.  BDNF and VEGF in the pathogenesis of stress-induced affective diseases: An insight from experimental studies , 2013, Pharmacological reports : PR.

[23]  R. Hen,et al.  BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities , 2013, Translational Psychiatry.

[24]  G. Rajkowska,et al.  Hippocampal volume and total cell numbers in major depressive disorder. , 2013, Journal of psychiatric research.

[25]  B. Czéh,et al.  Antidepressants act directly on astrocytes: Evidences and functional consequences , 2013, European Neuropsychopharmacology.

[26]  M. Banasr,et al.  Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. , 2013, The international journal of neuropsychopharmacology.

[27]  A. Czurkó,et al.  Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide , 2012, PloS one.

[28]  G. Aghajanian,et al.  Synaptic Dysfunction in Depression: Potential Therapeutic Targets , 2012, Science.

[29]  O. Cohen-Fix,et al.  Shaping the nucleus: Factors and forces , 2012, Journal of cellular biochemistry.

[30]  C. Hiemke,et al.  Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus , 2012, Psychopharmacology.

[31]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[32]  Zhen Yan,et al.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission , 2011, Nature Reviews Neuroscience.

[33]  Hui-ling Wang,et al.  Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression , 2011, Neuroscience Letters.

[34]  A. Simmons,et al.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.

[35]  P. Lucassen,et al.  Sex Differences in Adolescent Depression: Do Sex Hormones Determine Vulnerability? , 2011, Journal of neuroendocrinology.

[36]  M. Sullivan.  Treating Mood Disorders: No Easy Decisions , 2011 .

[37]  H. Sackeim,et al.  Necessity of Hippocampal Neurogenesis for the Therapeutic Action of Antidepressants in Adult Nonhuman Primates , 2011, PloS one.

[38]  R. Hen,et al.  Neurogenesis and affective disorders , 2011, The European journal of neuroscience.

[39]  G. Rajkowska,et al.  Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. , 2010, Journal of affective disorders.

[40]  H. Schmidt,et al.  A negative regulator of MAP kinase causes depressive behavior. , 2010, Nature medicine.

[41]  C. Zarate,et al.  Glutamatergic modulators: the future of treating mood disorders? , 2010, Harvard review of psychiatry.

[42]  P. Gebicke-haerter,et al.  Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression , 2010, Neuropharmacology.

[43]  Jin Yu,et al.  Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression , 2009, European Neuropsychopharmacology.

[44]  A. Johanson,et al.  Glial cell activation in response to electroconvulsive seizures , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[45]  M. Yücel,et al.  Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. , 2009, Journal of affective disorders.

[46]  Baoman Li,et al.  Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation , 2009, Psychopharmacology.

[47]  Alison Little,et al.  Treatment-resistant depression. , 2009, American family physician.

[48]  Joseph E LeDoux,et al.  The influence of stress hormones on fear circuitry. , 2009, Annual review of neuroscience.

[49]  H. Manji,et al.  The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[50]  O. Cohen-Fix,et al.  Sizing up the nucleus: nuclear shape, size and nuclear-envelope assembly , 2009, Journal of Cell Science.

[51]  H. Akil,et al.  A New Role for FGF2 as an Endogenous Inhibitor of Anxiety , 2009, The Journal of Neuroscience.

[52]  D. O'Malley,et al.  Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression , 2009, Neuroscience.

[53]  J. Overholser,et al.  Assessment of depression and suicidal actions: agreement between suicide attempters and informant reports. , 2009, Suicide & life-threatening behavior.

[54]  A. Wellstein,et al.  Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons , 2008, Neuropharmacology.

[55]  M. Banasr,et al.  Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors , 2008, Biological Psychiatry.

[56]  Mike Tyers,et al.  The size of the nucleus increases as yeast cells grow. , 2007, Molecular biology of the cell.

[57]  G. Meyer,et al.  Distribution patterns of estrogen receptor α and β in the human cortex and hippocampus during development and adulthood , 2007 .

[58]  S. Maier,et al.  Stress-induced glucocorticoids suppress the antisense molecular regulation of FGF-2 expression , 2007, Psychoneuroendocrinology.

[59]  B. Czéh,et al.  Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment , 2006, Neuropsychopharmacology.

[60]  P. Sedgwick,et al.  Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder , 2006, Brain Research Bulletin.

[61]  G. Sanacora,et al.  Beyond Monoamines: Glutamatergic Function in Mood Disorders , 2005, CNS Spectrums.

[62]  K. Krishnan,et al.  Prominent Reduction in Pyramidal Neurons Density in the Orbitofrontal Cortex of Elderly Depressed Patients , 2005, Biological Psychiatry.

[63]  G. Rajkowska,et al.  Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression , 2004, Neuropsychopharmacology.

[64]  J. Fawcett,et al.  The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. , 2004, Brain research. Molecular brain research.

[65]  E. Young,et al.  Puberty, Ovarian Steroids, and Stress , 2004, Annals of the New York Academy of Sciences.

[66]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[67]  Yogesh K. Dwivedi,et al.  Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. , 2003, Archives of general psychiatry.

[68]  C. Borror.  An Introduction to Statistical Methods and Data Analysis, 5th Ed. , 2002 .

[69]  F. Holsboer,et al.  Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus , 2001, The European journal of neuroscience.

[70]  Y. Hurd,et al.  Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders , 2001, Progress in Neurobiology.

[71]  B. Katzenellenbogen,et al.  Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[72]  G. Rajkowska,et al.  Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder , 2000, Biological Psychiatry.

[73]  G. Rajkowska,et al.  Immunohistochemistry of neural markers for the study of the laminar architecture in celloidin sections from the human cerebral cortex , 1999, Journal of Neuroscience Methods.

[74]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[75]  C. Finch,et al.  Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. , 1998, Endocrinology.

[76]  M. Seeman.  Psychopathology in women and men: focus on female hormones. , 1997, The American journal of psychiatry.

[77]  F. Gomez-Pinilla,et al.  Physical exercise induces FGF-2 and its mRNA in the hippocampus , 1997, Brain Research.

[78]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[79]  M Fujiki,et al.  High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. , 1997, Brain research. Molecular brain research.

[80]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Kessler,et al.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. , 1993, Journal of affective disorders.

[82]  R. Renkawitz,et al.  The glucocorticoid receptor. , 1991, Biochimica et biophysica acta.

[83]  N. Jahanshad,et al.  Subcortical brain alterations in major depressive disorder , 2015 .

[84]  Jian-xin Chen 陈建新,et al.  Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress , 2014, Journal of Huazhong University of Science and Technology [Medical Sciences].

[85]  Marie Osterlund.  Underlying mechanisms mediating the antidepressant effects of estrogens. , 2010, Biochimica et biophysica acta.

[86]  八幡 憲明,et al.  Structural neuroimaging studies in Asperger's syndrome , 2010 .

[87]  G. MacQueen,et al.  A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[88]  W J Riedel,et al.  Serotonergic vulnerability and depression: assumptions, experimental evidence and implications , 2007, Molecular Psychiatry.

[89]  R. Ravid,et al.  Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. , 2003, Experimental neurology.

[90]  E. Frank,et al.  Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. , 2000, Archives of general psychiatry.

[91]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[92]  A. Baba,et al.  [Glutamate transporter]. , 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[93]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[94]  R. Lyman Ott.,et al.  An introduction to statistical methods and data analysis , 1977 .